Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist

ACS Nano

Volumn 8, Issue 4, 2014, Pages 3678-3689

  Gao, Xihui ^a   Qian, Jun ^a   Zheng, Shuyan ^a   Changyi, Yinzhi ^a   Zhang, Jianping ^c   Ju, Shenghong ^b   Zhu, Jianhua ^a   Li, Cong ^a  

^a FUDAN UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

adenosine receptor; blood brain barrier; brain drug delivery; multimodal imaging; nanoagonist

Indexed keywords

BLOOD; DISEASES; ENDOTHELIAL CELLS; LIGANDS; MACROMOLECULES;

ADENOSINE RECEPTOR; BLOOD-BRAIN BARRIER; BRAIN DRUG DELIVERIES; MULTI-MODAL IMAGING; NANOAGONIST;

DRUG DELIVERY;

ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; DENDRIMER; DRUG CARRIER; NANOMATERIAL; PAMAM STARBURST;

ANIMAL; BLOOD BRAIN BARRIER; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG DESIGN; DRUG EFFECTS; METABOLISM; MOUSE; PERMEABILITY; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TIME;

ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE; DENDRIMERS; DRUG CARRIERS; DRUG DESIGN; MICE; NANOSTRUCTURES; PERMEABILITY; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TIME FACTORS;

EID: 84899443991     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn5003375     Document Type: Article

References (54)

1. Zlokovic, B. V. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders Neuron 2008, 57, 178-201
2. Ghose, A. K.; Viswanadhan, V. N.; Wendoloski, J. J. A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases J. Comb. Chem. 1999, 1, 55-68
3. Daneman, R. The Blood-Brain Barrier in Health and Disease Ann. Neurol. 2012, 72, 648-672
4. Abbott, N. J.; Patabendige, A. A.; Dolman, D. E.; Yusof, S. R.; Begley, D. J. Structure and Function of the Blood-Brain Barrier Neurobiol. Dis. 2010, 37, 13-25
5. Huber, J. D.; Egleton, R. D.; Davis, T. P. Molecular Physiology and Pathophysiology of Tight Junctions in the Blood-Brain Barrier Trends Neurosci. 2001, 24, 719-725
6. Pardridge, W. M. The Blood-Brain Barrier: Bottleneck in Brain Drug Development Neurorx 2005, 2, 3-14
7. Lipinski, C. A. Drug-Like Properties and the Causes of Poor Solubility and Poor Permeability J. Pharmacol. Toxicol. Methods 2000, 44, 235-249
8. Sarin, H.; Kanevsky, A. S.; Wu, H.; Sousa, A. A.; Wilson, C. M.; Aronova, M. A.; Griffiths, G. L.; Leapman, R. D.; Vo, H. Q. Physiologic Upper Limit of Pore Size in the Blood-Tumor Barrier of Malignant Solid Tumors J. Transl. Med. 2009, 7, 51
9. Gao, X.; Li, C. Nanoprobes Visualizing Gliomas by Crossing the Blood Brain Tumor Barrier. Small 2013, DOI: 10.1002/smll.201301673.
10. Jiang, Q.; Ewing, J. R.; Chopp, M. MRI of Blood-Brain Barrier Permeability in Cerebral Ischemia Transl. Stroke Res. 2012, 3, 56-64
11. Belayev, L.; Busto, R.; Zhao, W.; Ginsberg, M. D. Quantitative Evaluation of Blood-Brain Barrier Permeability Following Middle Cerebral Artery Occlusion in Rats Brain Res. 1996, 739, 88-96
12. Bowman, G. L.; Kaye, J. A.; Moore, M.; Waichunas, D.; Carlson, N. E.; Quinn, J. F. Blood-Brain Barrier Impairment in Alzheimer Disease: Stability and Functional Significance Neurology 2007, 68, 1809-1814
13. Weiss, N.; Miller, F.; Cazaubon, S.; Couraud, P. O. The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases Biochim. Biophys. Acta 2009, 1788, 842-857
14. Lee, G.; Dallas, S.; Hong, M.; Bendayan, R. Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev. 2001, 53, 569-596
15. Liu, H. L.; Hua, M. Y.; Chen, P. Y.; Chu, P. C.; Pan, C. H.; Yang, H. W.; Huang, C. Y.; Wang, J. J.; Yen, T. C.; Wei, K. C. Blood-Brain Barrier Disruption with Focused Ultrasound Enhances Delivery of Chemotherapeutic Drugs for Glioblastoma Treatment Radiology 2010, 255, 415-425
16. Bobo, R. H.; Laske, D. W.; Akbasak, A.; Morrison, P. F.; Dedrick, R. L.; Oldfield, E. H. Convection-Enhanced Delivery of Macromolecules in the Brain Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 2076-2080
17. Allard, E.; Passirani, C.; Benoit, J. P. Convection-Enhanced Delivery of Nanocarriers for the Treatment of Brain Tumors Biomaterials 2009, 30, 2302-2318
18. Rapoport, S. I. Osmotic Opening of the Blood-Brain Barrier: Principles, Mechanism, and Therapeutic Applications Cell. Mol. Neurobiol. 2000, 20, 217-230
19. Neuwelt, E. A.; Barnett, P. A.; Glasberg, M.; Frenkel, E. P. Pharmacology and Neurotoxicity of Cis-Diamminedichloroplatinum, Bleomycin, 5-Fluorouracil, and Cyclophosphamide Administration Following Osmotic Blood-Brain Barrier Modification Cancer Res. 1983, 43, 5278-5285
20. Marchi, N.; Angelov, L.; Masaryk, T.; Fazio, V.; Granata, T.; Hernandez, N.; Hallene, K.; Diglaw, T.; Franic, L.; Najm, I. et al. Seizure-Promoting Effect of Blood-Brain Barrier Disruption Epilepsia 2007, 48, 732-742
21. Hynynen, K. Ultrasound for Drug and Gene Delivery to the Brain Adv. Drug Delivery Rev. 2008, 60, 1209-1217
22. Kinoshita, M.; McDannold, N.; Jolesz, F. A.; Hynynen, K. Noninvasive Localized Delivery of Herceptin to the Mouse Brain by Mri-Guided Focused Ultrasound-Induced Blood-Brain Barrier Disruption Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 11719-11723
23. Tuma, P.; Hubbard, A. L. Transcytosis: Crossing Cellular Barriers Physiol. Rev. 2003, 83, 871-932
24. Herve, F.; Ghinea, N.; Scherrmann, J. M. CNS Delivery via Adsorptive Transcytosis AAPS J. 2008, 10, 455-472
25. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Wagner, S.; Buchel, C.; von Briesen, H.; Kreuter, J. Albumin Nanoparticles Targeted with Apo E Enter the CNS by Transcytosis and Are Delivered to Neurones J. Controlled Release 2009, 137, 78-86
26. Yan, H.; Wang, J.; Yi, P.; Lei, H.; Zhan, C.; Xie, C.; Feng, L.; Qian, J.; Zhu, J.; Lu, W. et al. Imaging Brain Tumor by Dendrimer-Based Optical/Paramagnetic Nanoprobe across the Blood-Brain Barrier Chem. Commun. 2011, 47, 8130-8132
27. Jacobson, K. A.; Gao, Z. G. Adenosine Receptors as Therapeutic Targets Nat. Rev. Drug Discovery 2006, 5, 247-264
28. Carman, A. J.; Mills, J. H.; Krenz, A.; Kim, D. G.; Bynoe, M. S. Adenosine Receptor Signaling Modulates Permeability of the Blood-Brain Barrier J. Neurosci. 2011, 31, 13272-13280
29. Sohail, M. A.; Hashmi, A. Z.; Hakim, W.; Watanabe, A.; Zipprich, A.; Groszmann, R. J.; Dranoff, J. A.; Torok, N. J.; Mehal, W. Z. Adenosine Induces Loss of Actin Stress Fibers and Inhibits Contraction in Hepatic Stellate Cells via Rho Inhibition Hepatology 2009, 49, 185-194
30. de Lera Ruiz, M.; Lim, Y.-H.; Zheng, J. Adenosine A2a Receptor as a Drug Discovery Target J. Med. Chem. 2013, 10.1021/jm4011669
31. Albanese, A.; Tang, P. S.; Chan, W. C. The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems Annu. Rev. Biomed. Eng. 2012, 14, 1-16
32. Willmann, J. K.; van Bruggen, N.; Dinkelborg, L. M.; Gambhir, S. S. Molecular Imaging in Drug Development Nat. Rev. Drug Discovery 2008, 7, 591-607
33. Barrett, T.; Ravizzini, G.; Choyke, P. L.; Kobayashi, H. Dendrimers in Medical Nanotechnology IEEE Eng. Med. Biol. Mag. 2009, 28, 12-22
34. Choi, J. J.; Wang, S.; Tung, Y. S.; Morrison, B., 3rd; Konofagou, E. E. Molecules of Various Pharmacologically-Relevant Sizes Can Cross the Ultrasound-Induced Blood-Brain Barrier Opening in Vivo Ultrasound Med. Biol. 2010, 36, 58-67
35. Armulik, A.; Genove, G.; Mae, M.; Nisancioglu, M. H.; Wallgard, E.; Niaudet, C.; He, L.; Norlin, J.; Lindblom, P.; Strittmatter, K. et al. Pericytes Regulate the Blood-Brain Barrier Nature 2010, 468, 557-561
36. Caulkett, P. W. R.; Jones, G.; McPartlin, M.; Renshaw, N. D.; Stewart, S. K.; Wright, B. Adenine Isosteres with Bridgehead Nitrogen. Part 1. Two Independent Syntheses of the [1,2,4]Triazolo[1,5-a][1,3,5]Triazine Ring System Leading to a Range of Substituents in the 2, 5 and 7 Positions J. Chem. Soc., Perkins Trans. 1 1995, 801-808
37. Neuwelt, E. A.; Frenkel, E. P.; D'Agostino, A. N.; Carney, D. N.; Minna, J. D.; Barnett, P. A.; McCormick, C. I. Growth of Human Lung Tumor in the Brain of the Nude Rat as a Model to Evaluate Antitumor Agent Delivery across the Blood-Brain Barrier Cancer Res. 1985, 45, 2827-2833
38. Daneman, R.; Zhou, L.; Kebede, A. A.; Barres, B. A. Pericytes Are Required for Blood-Brain Barrier Integrity during Embryogenesis Nature 2010, 468, 562-566
39. Dixon, A. K.; Gubitz, A. K.; Sirinathsinghji, D. J.; Richardson, P. J.; Freeman, T. C. Tissue Distribution of Adenosine Receptor Mrnas in the Rat Br. J. Pharmacol. 1996, 118, 1461-1468
40. Thal, S. C.; Luh, C.; Schaible, E. V.; Timaru-Kast, R.; Hedrich, J.; Luhmann, H. J.; Engelhard, K.; Zehendner, C. M. Volatile Anesthetics Influence Blood-Brain Barrier Integrity by Modulation of Tight Junction Protein Expression in Traumatic Brain Injury PLoS One 2012, 7, e50752
41. Kobzik, L. Lung Macrophage Uptake of Unopsonized Environmental Particulates. Role of Scavenger-Type Receptors J. Immunol. 1995, 155, 367-376
42. Yang, J.; Wadghiri, Y. Z.; Hoang, D. M.; Tsui, W.; Sun, Y.; Chung, E.; Li, Y.; Wang, A.; de Leon, M.; Wisniewski, T. Detection of Amyloid Plaques Targeted by Uspio-Abeta1-42 in Alzheimer's Disease Transgenic Mice Using Magnetic Resonance Microimaging Neuroimage 2011, 55, 1600-1609
43. Wang, M.; Etu, J.; Joshi, S. Enhanced Disruption of the Blood Brain Barrier by Intracarotid Mannitol Injection during Transient Cerebral Hypoperfusion in Rabbits J. Neurosurg. Anesthesiol. 2007, 19, 249-256
44. Elzein, E.; Kalla, R.; Li, X.; Perry, T.; Marquart, T.; Micklatcher, M.; Li, Y.; Wu, Y.; Zeng, D.; Zablocki, J. N6-Cycloalkyl-2-Substituted Adenosine Derivatives as Selective, High Affinity Adenosine A1 Receptor Agonists Bioorg. Med. Chem. Lett. 2007, 17, 161-166
45. a Calculations of Aliphatic Amines, Diamines, and Aminoamides via Density Functional Theory with a Poisson-Boltzmann Continuum Solvent Model J. Phys. Chem. A 2007, 111, 4422-4430
46. Kim, Y.; Hechler, B.; Klutz, A. M.; Gachet, C.; Jacobson, K. A. Toward Multivalent Signaling across G Protein-Coupled Receptors from Poly(Amidoamine) Dendrimers Bioconjugate Chem. 2008, 19, 406-411
47. Tosh, D. K.; Yoo, L. S.; Chinn, M.; Hong, K.; Kilbey, S. M., 2nd; Barrett, M. O.; Fricks, I. P.; Harden, T. K.; Gao, Z. G.; Jacobson, K. A. Polyamidoamine (PAMAM) Dendrimer Conjugates of "Clickable" Agonists of the A3 Adenosine Receptor and Coactivation of the P2y14 Receptor by a Tethered Nucleotide Bioconjugate Chem. 2010, 21, 372-384
48. Kiessling, L. L.; Gestwicki, J. E.; Strong, L. E. Synthetic Multivalent Ligands as Probes of Signal Transduction Angew. Chem., Int. Ed. 2006, 45, 2348-2368
49. Leach, K.; Sexton, P. M.; Christopoulos, A. Allosteric GPCR Modulators: Taking Advantage of Permissive Receptor Pharmacology Trends Pharmacol. Sci. 2007, 28, 382-389
50. Das, A.; Zhou, Y.; Ivanov, A. A.; Carter, R. L.; Harden, T. K.; Jacobson, K. A. Enhanced Potency of Nucleotide-Dendrimer Conjugates as Agonists of the P2y14 Receptor: Multivalent Effect in G Protein-Coupled Receptor Recognition Bioconjugate Chem. 2009, 20, 1650-1659
51. Ribeiro, J. A.; Sebastiao, A. M.; de Mendonca, A. Adenosine Receptors in the Nervous System: Pathophysiological Implications Prog. Neurobiol. 2002, 68, 377-392
52. Yan, H.; Wang, L.; Wang, J.; Weng, X.; Lei, H.; Wang, X.; Jiang, L.; Zhu, J.; Lu, W.; Wei, X. et al. Two-Order Targeted Brain Tumor Imaging by Using an Optical/Paramagnetic Nanoprobe across the Blood Brain Barrier ACS Nano 2012, 6, 410-420
53. Li, C.; Winnard, P., Jr.; Bhujwalla, Z. M. Facile Synthesis of 1-(Acetic Acid)-4,7,10-Tris(tert-Butoxycarbonylmethyl)-1,4,7,10-Tetraaza-Cyclododecane: A Reactive Precursor Chelating Agent Tetrahedron Lett. 2009, 50, 2929-2931
54. Alexander, S. P.; Millns, P. J. [(3)H]Zm241385-an Antagonist Radioligand for Adenosine a(2a) Receptors in Rat Brain Eur. J. Pharmacol. 2001, 411, 205-210